Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 4/20 | 0.40 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.37 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6709872 | 1.00 | FDPS (0.40) | FDPSZDHHC7LMNADNM1TSHR | |
| Octane SCHEMBL28228277 | 1.00 | FDPS (0.40) | FDPSZDHHC7LMNADNM1TSHR | |
| SCHEMBL336029 | 1.00 | FDPS (0.40) | FDPSZDHHC7LMNADNM1TSHR | |
| SCHEMBL15332850 | 1.00 | FDPS (0.40) | FDPSZDHHC7LMNADNM1TSHR | |
| SCHEMBL1639182 | 1.00 | FDPS (0.40) | FDPSZDHHC7LMNADNM1TSHR | |
| SCHEMBL6709875 | 1.00 | FDPS (0.40) | FDPSZDHHC7LMNADNM1TSHR | |
| SCHEMBL6708378 | 1.00 | FDPS (0.40) | FDPSZDHHC7LMNADNM1TSHR | |
| SCHEMBL335823 | 0.98 | OPRM1 (0.39) | FDPSZDHHC7LMNADNM1TSHR | |
| SCHEMBL28256040 | 0.95 | OPRM1 (0.37) | FDPSZDHHC7LMNADNM1TSHR | |
| SCHEMBL1639966 | 0.90 | DNM1 (0.36) | FDPSLMNADNM1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 232 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024040271-A1 | MOISTURE CURABLE SILICONE POLYETHYLENEIMINE RESIN | HENKEL AG & CO. KGAA (DE) | 2024-02-22 | — | — | WO | claimed |
| WO-2024040272-A1 | COSMETIC COLORING COMPOSITIONS CONTAINING MOISTURE CURABLE SILICONE POLYETHYLENEIMINE RESIN | HENKEL AG & CO. KGAA (DE) | 2024-02-22 | — | — | WO | claimed |
| WO-2024004242-A1 | THERMALLY CONDUCTIVE COMPOSITION, THERMALLY CONDUCTIVE GREASE AND THERMALLY CONDUCTIVE SHEET | 富士高分子工業株式会社 | 2024-01-04 | — | — | WO | claimed |
| US-10323182-B2 | Nanocrystal-metal oxide composite, methods of manufacture thereof and articles comprising the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-06-18 | — | — | US | claimed |
| EP-2785178-B1 | OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE | BIKAM PHARMACEUTICALS INC (US) | 2019-05-01 | — | — | EP | claimed |
| US-20190023649-A1 | Opsin-Binding Ligands, Compositions and Methods of Use | BIKAM PHARMACEUTICALS, INC. (US) | 2019-01-24 | — | — | US | claimed |
| EP-3426388-A1 | SUPERFICIALLY POROUS MATERIALS COMPRISING A COATED CORE HAVING NARROW PARTICLE SIZE DISTRIBUTION; PROCESS FOR THE PREPARATION THEREOF; AND USE THEREOF FOR CHROMATOGRAPHIC SEPARATIONS | Waters Technologies Corporation (US) | 2019-01-16 | — | — | EP | claimed |
| US-10040749-B2 | Opsin-binding ligands, compositions and methods of use | BIKAM PHARMACEUTICALS INC. (US) | 2018-08-07 | — | — | US | claimed |
| EP-2390296-B1 | Aqueous siloxane coating composition, making method, surface treating agent, surface treated steel, and coated steel | SHINETSU CHEMICAL CO (JP) | 2018-06-20 | — | — | EP | claimed |
| US-20150038574-A1 | Opsin-Binding Ligands, Compositions and Methods of Use | BIKAM PHARMACEUTICALS, INC. (US) | 2015-02-05 | — | — | US | claimed |
| US-7345000-B2 | Method and system for treating a dielectric film | TOKYO ELECTRON LIMITED (JP) | 2008-03-18 | — | — | US | claimed |
| WO-2007040834-A2 | PLURAL TREATMENT STEP PROCESS FOR TREATING DIELECTRIC FILMS | TOKYO ELECTRON LIMITED (JP) | 2007-04-12 | — | — | WO | claimed |
| WO-2007040816-A2 | TREATMENT OF LOW DIELECTRIC CONSTANT FILMS USING A BATCH PROCESSING SYSTEM | TOKYO ELECTRON LIMITED (JP) | 2007-04-12 | — | — | WO | claimed |
| WO-2007040856-A2 | PLASMA-ASSISTED VAPOR PHASE TREATMENT OF LOW DIELECTRIC CONSTANT FILMS USING A BATCH PROCESSING SYSTEM | TOKYO ELECTRON LIMITED (JP) | 2007-04-12 | — | — | WO | claimed |
| US-20070077782-A1 | Treatment of low dielectric constant films using a batch processing system | TOKYO ELECTRON LIMITED (JP) | 2007-04-05 | — | — | US | claimed |
| US-20070077353-A1 | Plasma-assisted vapor phase treatment of low dielectric constant films using a batch processing system | TOKYO ELECTRON LIMITED (JP) | 2007-04-05 | — | — | US | claimed |
| US-20070077781-A1 | Plural treatment step process for treating dielectric films | TOKYO ELECTRON LIMTED (JP) | 2007-04-05 | — | — | US | claimed |
| WO-2006091264-A1 | METHOD AND SYSTEM FOR TREATING A DIELECTRIC FILM | TOKYO ELECTRON LIMITED (JP) | 2006-08-31 | — | — | WO | claimed |
| US-20050215072-A1 | Method and system for treating a dielectric film | TOKYO ELECTRON LIMITED (JP) | 2005-09-29 | — | — | US | claimed |
| US-20040146766-A1 | Proton electrolyte membranes, methods of making proton electrolyte membranes, and methods of use thereof | GEORGIA TECH RESEARCH CORPORATION | 2004-07-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150038574-A1 | Opsin-Binding Ligands, Compositions and Methods of Use | CRYAB, CRYAA, PDE6C | FDPS 3207/4885ZDHHC7 2952/4885LMNA 2942/4885 |
| US-10040749-B2 | Opsin-binding ligands, compositions and methods of use | CRYAB, CRYAA, PDE6C | FDPS 3207/4885ZDHHC7 2952/4885LMNA 2942/4885 |
| US-20190023649-A1 | Opsin-Binding Ligands, Compositions and Methods of Use | CRYAB, CRYAA, PDE6C | FDPS 3207/4885ZDHHC7 2952/4885LMNA 2942/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.